Patents by Inventor Gram Dorte Xenia

Gram Dorte Xenia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110098440
    Abstract: An acylated insulin analogue wherein the insulin analogue comprises a lysine residue connected C-terminally to the A21 amino acid residue or a peptide residue of up to 4 amino acid residues comprising a lysine residue which peptide residue is connected C-terminally to the A21 amino acid residue, characterized in that an acyl moiety comprising an alkylene glycol moiety is attached to the lysine residue in the A22 position or attached to a lysine residue present in the peptide residue that is attached to the C terminal end of the A21 amino acid residue and wherein there is only one lysine (K, Lys) in the insulin analogue, can conveniently be administered pulmonary.
    Type: Application
    Filed: August 15, 2008
    Publication date: April 28, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Peter Madsen, Kjeldsen Thomas Borglum, Hoeg-Jensen Thomas, Tagmose Tina Moller, Jakobsen Palle, Kodra János Tibor, Garbay Patrick William, Gram Dorte Xenia